Necrostatin-5

CAS No. 337349-54-9

Necrostatin-5( —— )

Catalog No. M34958 CAS No. 337349-54-9

Necrostatin-5 (Nec-5) is a selective RIP1 kinase inhibitor and cell necrosis inhibitor that prevents the death of Fadd-deficient Jurkat cells treated with TNF-α, with an EC50 of 240 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 36 In Stock
25MG 84 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Necrostatin-5
  • Note
    Research use only, not for human use.
  • Brief Description
    Necrostatin-5 (Nec-5) is a selective RIP1 kinase inhibitor and cell necrosis inhibitor that prevents the death of Fadd-deficient Jurkat cells treated with TNF-α, with an EC50 of 240 nM.
  • Description
    Necrostatin-5 (Nec-5) is a potent necroptosis inhibitor with an EC50 value of 0.24 μM. Necrostatin-5 also is a RIP1 inhibitor. Necrostatin-5 shows cardioprotective effects.
  • In Vitro
    ——
  • In Vivo
    Animal Model:200-300 g, male Wistar rats Dosage:2.46 mg/kg Administration:I.p.; 60 min before experiment Result:Reduced the infarction zone caused by 30-min global ischemia and 120-min reperfusion.
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    RIP kinase
  • Recptor
    RIP kinase | Necroptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    337349-54-9
  • Formula Weight
    383.49
  • Molecular Formula
    C19H17N3O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (13.04 mM; Ultrasonic (<60°C)
  • SMILES
    O=C1C=2C3=C(SC2N=C(SCC#N)N1C4=CC=C(OC)C=C4)CCCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang K, et al. Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5. Bioorg Med Chem Lett. 2007 Mar 1;17(5):1455-65. ?
molnova catalog
related products
  • WEHI-345

    A potent and selective RIPK2 inhibitor with IC50/Kd of 130/46 nM; displays negligible activity (>10 uM) against RIPK1, RIPK4 and RIPK5.

  • RIPK2-IN-8

    A potent, selective, orally available RIPK2 inhibitor with IC50 of 3 nM.

  • GSK-2982772

    GSK-2982772 is a potent, selective, ATP competitive RIP1 kinase inhibitor with IC50 of 16 nM.